FDA ANDA · ANDA201588
OLANZAPINE
Sponsor: SANDOZ INC
What this page does not claim
A drug page is a reference view of public FDA data (Drugs@FDA), reproduced as published. SPEQ is not affiliated with the FDA, adds no interpretation to the record, and nothing here is medical, legal, or regulatory advice.
APPLICATION
ANDA201588
TYPE
ANDA
ORIGINAL APPROVAL
2011-10-24
LATEST ACTION
2026-10-01
ROUTE
INTRAMUSCULAR
DOSAGE FORM
POWDER
MARKETING STATUS
Prescription
Products
OLANZAPINEPrescription
OLANZAPINE 10MG/VIAL · POWDER · INTRAMUSCULAR
Approval history
2026-10-01Labeling · Supplement 17 · standardAP
2026-10-01Labeling · Supplement 18 · standardAP
2024-05-29Labeling · Supplement 6 · standardAP
2024-05-29Labeling · Supplement 11 · standardAP
2024-05-29Labeling · Supplement 9 · standardAP
2024-05-29Labeling · Supplement 3 · standardAP
2024-05-29Labeling · Supplement 10 · standardAP
Source: FDA Drugs@FDA. Browse every approval SPEQ tracks →